{"metadata": {"source": "psychonaut_CSV", "row": 36, "doc_id": "doc_265", "num_chunks": 38, "chunk_id": "265::chunk_35", "document_index": 265, "latency_s": 0.8425881000002846, "prompt_toks": 6026, "completion_toks": 89, "relevance_score": 0.0017007225}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    - External hallucination ( autonomous entities ; settings, sceneries, and landscapes ; perspective hallucinations and scenarios and plots )\nAuditory effects: - Auditory enhancement - Some users report an enhanced sense of hearing on LSD. However, there is currently no clinical evidence supporting this claim. Auditory distortion - Sounds may appear \"tinny\" or \"alien\". More likely at higher doses.  Certain subjective reports mention flanging, delays/echoing, reverb -like effects, similar to those found in music. Auditory hallucination - Typically present at higher doses. Not as common as visual hallucinations, but may occur alongside them.\n- Auditory enhancement - Some users report an enhanced sense of hearing on LSD. However, there is currently no clinical evidence supporting this claim.\n\n\n                    Context: \n                    This excerpt details LSD's auditory and multi-sensory effects, including potential enhancements and distortions in hearing, hallucinations, and synesthetic experiences. It fits within the larger section on visual, auditory, and multi-sensory hallucinations, highlighting how LSD influences sensory perception at higher doses. Key points include reports of increased hearing sensitivity, sounds appearing \"tinny\" or \"alien,\" and auditory hallucinations that may occur alongside visual effects.\n                "}
{"metadata": {"source": "pubchem", "title": "Meperidine | C15H21NO2 | CID 4058 - PubChem", "description": "Meperidine | C15H21NO2 | CID 4058 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4058", "drug": "Meperidine", "cid": 4058, "char_count": 152237, "word_count": 20244, "doc_id": "doc_47", "num_chunks": 222, "chunk_id": "47::chunk_40", "document_index": 47, "latency_s": 1.391585400007898, "prompt_toks": 39517, "completion_toks": 86, "relevance_score": 0.001477943}, "content": "Drug: Meperidine | cid: 4058\nSource: pubchem | Source description: Meperidine | C15H21NO2 | CID 4058 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    of action than does morphine. Following oral administration of meperidine, peak analgesia occurs within one hour and gradually declines over 2-4 hours. Peak analgesia occurs about 40-60 minutes after subcutaneous administration and 30-50 minutes after IM administration. Analgesia may be maintained for 2-4 hours following subcutaneous or IM administration.\n\n\n                    Context: \n                    This excerpt details the pharmacokinetics of meperidine's analgesic effects, specifying peak onset times and duration after different administration routes. It is relevant within the document's pharmacology section, highlighting the drug's onset and duration of action, which are critical for clinical use and for understanding its efficacy and dosing considerations. These details enhance search retrieval related to pharmacokinetics, administration routes, and duration of analgesia.\n                "}
{"metadata": {"source": "pubchem", "title": "Hydromorphone | C17H19NO3 | CID 5284570 - PubChem", "description": "Hydromorphone | C17H19NO3 | CID 5284570 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5284570", "drug": "Hydromorphone", "cid": 5284570, "char_count": 132462, "word_count": 17415, "doc_id": "doc_30", "num_chunks": 191, "chunk_id": "30::chunk_131", "document_index": 30, "latency_s": 1.3788211999926716, "prompt_toks": 35006, "completion_toks": 84, "relevance_score": 0.0010608152}, "content": "Drug: Hydromorphone | cid: 5284570\nSource: pubchem | Source description: Hydromorphone | C17H19NO3 | CID 5284570 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    /VETERINARY CASE REPORTS/ /The objective of the study was/ to evaluate the antinociceptive and sedative effects and duration of action of hydromorphone hydrochloride after IM administration to /11 healthy 2-year-old/ American kestrels (Falco sparverius). ... Hydromorphone (0.1, 0.3, and 0.6 mg/kg) and an equivalent volume of saline (0.9% NaCl) solution (control treatment) were administered IM to kestrels in a masked randomized complete crossover study design. Foot withdrawal response to a thermal stimulus was determined 30 to 60 minutes before (baseline) and 0.5, 1.5, 3, and 6 hours after treatment administration. Agitation-sedation scores were determined 3 to 5 minutes before each thermal test. Hydromorphone at 0.6 mg/kg, IM, significantly increased the thermal foot withdrawal threshold, compared with the response after administration of saline solution, for up to 3 hours, and hydromorphone at 0.1, 0.3, and 0.6 mg/kg, IM, significantly increased withdrawal responses for up to 6\n\n\n                    Context: \n                    This excerpt details a veterinary case report on the antinociceptive and sedative effects of hydromorphone hydrochloride administered IM to American kestrels, highlighting dose-dependent increases in pain threshold and duration of effect. It complements the full document’s comprehensive data on hydromorphone's pharmacology, toxicity, and species-specific effects, providing specific experimental results relevant for veterinary and research contexts.\n                "}
